Home
Conditions
Neuroendocrine Tumors

Clinical trial condition

Neuroendocrine Tumors

Explore clinical trials studying Neuroendocrine Tumors. Study availability and eligibility vary by location and protocol.

2,767 public trials 494 recruiting studies

Refine in advanced search Browse all conditions

Neuroendocrine Tumors trial results

Completed

PF-3512676 (CPG 7909) Injection For Patients Who Completed An Oncology Study Using PF-3512676 (CPG 7909)

NCT00043368

Conditions: Adenocarcinoma, Breast Diseases, Breast Neoplasms, +40 more
Locations: Pfizer Investigational Site Berkely, California, United States

Pfizer Investigational Site Gilroy, California, United States

Pfizer Investigational Site Hollister, California, United States

Pfizer Investigational Site Los Angeles, California, United States

View all 32 locations

View Trial Details

Completed

Study of Interleukin-21 for Metastatic Malignant Melanoma and Metastatic Kidney Cancer

NCT00095108

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +27 more
Locations: University of Michigan Comprehensive Cancer Center Ann Arbor, Michigan, United States

University of Washington/Seattle Cancer Care Alliance Seattle, Washington, United States

View Trial Details

Completed

Dendritic Cell Vaccination in Melanoma Patients Scheduled for Regional Lymph Node Dissection

NCT00243594

Conditions: Melanoma, Melanoma Stage III or IV, Neoplasms, +10 more
Locations: Radboud University Nijmegen Medical Centre Nijmegen, PO Box 9101, Netherlands

View Trial Details

Completed

Augmentation of Dendritic Cell-Based Vaccines in Melanoma Patients by Depletion of Regulatory T Cells in Stage IV Melanoma Patients

NCT00847106

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Not specified

View Trial Details

Completed

CPG 7909 Injection in Melanoma

NCT00070642

Conditions: Carcinoma, Carcinoma, Melanoma, Melanoma, +12 more
Locations: Not specified

View Trial Details

Completed

Exploratory, Phase 0 Study of Positron Emission Tomography (PET) Imaging Agent, F-18 RGD-K5

NCT00743353

Conditions: Astrocytoma, Breast Cancer, Breast Diseases, +29 more
Locations: Fox Chase Cancer Center Philadelphia, Pennsylvania, United States

View Trial Details

Completed

Use of 852A in Metastatic Cutaneous Melanoma.

NCT00189332

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +10 more
Locations: Hôpital Hotel Dieu, 1, Pace de l' Hôpital, Lyon, France

Hôpital Ste Marguerite,Service de Dermatologie Marseille, France

Hautklinik, Medizinische Einrichtungen der Heinrich-Heine - Universität Düsseldorf Düsseldorf, Germany

Klinik und Poliklinik für Dermatologie und Venerologie Universitätsklinikum Essen Essen, Germany

View Trial Details

Completed

Safety and Efficacy of an Immune Response Modifier to Treat Inoperable Advanced Melanoma Skin Lesions

NCT00091689

Conditions: Melanoma, Neoplasms, Neoplasms by Histologic Type, +9 more
Locations: Dartmouth-Hitchcock Medical Center Lebanon, New Hampshire, United States

Oklahoma Medical Research Foundation Oklahoma City, Oklahoma, United States

View Trial Details

Completed

Modified Bone Marrow Stem Cell Transplantation for Chronic Myelogenous Leukemia

NCT00001144

Conditions: Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +23 more
Locations: National Heart, Lung and Blood Institute (NHLBI) Bethesda, Maryland, United States

View Trial Details

Completed

Volociximab in Combination With DTIC in Patients With Metastatic Melanoma Not Previously Treated With Chemotherapy

NCT00099970

Conditions: Melanoma, Metastases, Neoplasm Metastasis, +14 more
Locations: University of Alabama at Birmingham-Comprehensive Cancer Ctr. Birmingham, Alabama, United States

Arizona Cancer Center Tucson, Arizona, United States

UCLA School of Medicine Los Angeles, California, United States

Cancer Institute Medical Group, Inc. Santa Monica, California, United States

View Trial Details

Neuroendocrine Tumors

Neuroendocrine Tumors trial results

Related conditions